Skip to main content
. Author manuscript; available in PMC: 2009 Oct 20.
Published in final edited form as: Pediatrics. 2009 Jul;124(1):e137–e144. doi: 10.1542/peds.2008-1873

Table 3.

Early neonatal morbidity and mortality according to maternal intrapartum antibiotic receipt (non-ITT analysis; actual receipt of antibiotics analysis).

Outcome Category Maternal Receipt of Intrapartum Antibiotics (N=1033) No Maternal Receipt of Intrapartum Antibiotics (N=1380) Odds ratio [95% CI] P-value
n/N % n/N %
Infant illness at birth Yes 115/1031 11.2 118/1375 8.6 1.3 [1.0 – 1.8] 0.03
Admission to SCBUa Yes 117/925 12.6 116/1181 9.8 1.4 [1.1 – 1.9] 0.04
Early neonatal infection Yes 104/1033 10.1 137/1380 9.9 1.0 [0.8 – 1.3] 0.91
Duration of SCBU stay (days)b Mean 5.3 - - 6 0.80c 0.80c
Early neonatal death Yes 37/1033 3.6 47/1380 3.4 1.1 [0.7 – 1.6] 0.82
Dead 30/116 25.9 25/115 21.7
Vital status at discharge from SCBUb Alive and unwell 9/116 7.8 5/115 4.3 0.37
Alive and well 77/116 66.4 85/115 73.9
Deaths due to infectious causes Yes 8/37 21.6 5/47 10.6 0.23
Neonatal infections with unknown HIV statusd Yes 3/54 5.6 0/93 0 0.02
a

SCBU= Special Care Baby Unit

b

Among those admitted to SCBU

c

Wilcoxon test

d

Neonatal infections and neonatal deaths by infant’s birth HIV status among HIV exposed infants only